Home/All Products/Product Details
Sort by:
Rotavirus vaccine
All Products
Combination Vaccines
Diphtheria-tetanus-acellular pertssis vaccine (DTaP)
Indications
Prevention of Diphtheria, Tetanus and Pertussis
GMP compliance
PIC/S
Dosage & instruction of use
0.5ml, Intramuscular injection
Shelf life
2 years
Description
DTaP vaccine is a 3-in-1 combination vaccine given to protect against Diphtheria, Tetanus and Pertussis. It is recommended for children below 7 years old to receive 5 doses at 2, 4, 6 months, between 15 and 18 months, and between 4 and 6 years respectively. Our DTaP vaccine is made using Park-Williams No. 8 strain of Corynebacterium Diphtheriae, Harvard A-47 Strain of Clostridium Tetani and Tohama strain of Bordetella Pertussis. This product is supplied in pre-filled syringe, with no thimerosal nor other preservatives used in the production.
vaccine development company
All Products
Combination Vaccines
Diphtheria-tetanus-acellular pertussis and polio vaccine (DTaP-IPV)
Indications
Prevention of Diphtheria, Tetanus, Pertussis and Poliomyelitis
GMP compliance
PIC/S
Dosage & instruction of use
0.5ml, Intramuscular injection
Shelf life
3 years
Description
DTaP-IPV vaccine is a 4-in-1 vaccine given to protect against Diphtheria, Tetanus, Pertussis and Poliovirus. It is recommended for children younger than 7 years old to receive 5 doses at 2, 4, 6 months, between 15 and 18 months, and between 4 and 6 years respectively. Our DTaP-IPV is made using Park-Williams No. 8 strain of Corynebacterium Diphtheriae, Harvard A-47 strain of Clostridium Tetani, Tohama Strain of Bordetella Pertussis and Salk strains of Poliovirus. This product is supplied in pre-filled syringe, with no thimerosal used in the production.
vaccine supply
All Products
Bacterial Vaccines
Tetanus vaccine (TT)
Indications
Prevention of Tetanus
GMP compliance
EU & PIC/S
Dosage & instruction of use
0.5ml, Intramuscular injection
Shelf life
3 years
Description
Tetanus vaccine is given to protect against Tetanus infection. It is recommended for children, adolescents and adults. For primary immunization, 2 doses shall be vaccinated in 4-6 weeks interval, followed by the 3rd dose after 6-12 months. Individuals can receive a booster dose in 10 years interval. This product is supplied in ampoule, with no thimerosal used in the production.
hand foot mouth disease vaccine
All Products
Bacterial Vaccines
Tetanus and diphtheria vaccine (Td)
Indications
Prevention of Tetanus and Diphtheria
GMP compliance
EU & PIC/S
Dosage & instruction of use
0.5ml, Intramuscular injection
Shelf life
3 years
Description
Td vaccine is given to protect against Tetanus and Diphtheria infections. Individuals 7 years and above with no Tetanus and Diphtheria vaccination is recommended to receive the first 2 doses in 4-6 weeks interval, followed by the 3rd dose after 6-12 months as primary immunization. Individuals can also receive a booster dose in 10 years interval. This product is supplied in ampoule, with no thimerosal used in the production.
Hepatitis A vaccine
All Products
Viral Vaccines
Inactivated polio (Salk) vaccine (IPV)
Indications
Prevention of Poliomyelitis
GMP compliance
EU & PIC/S
Dosage & instruction of use
0.5ml, Intramuscular injection
Shelf life
3 years
Description
IPV is given to protect against Poliomyelitis. It is recommended for children 2 months and above to receive a total of 3 doses with at least 4 weeks intervals between each vaccination. Our IPV is made of Salk strains including type 1 Mahoney strain, type 2 MEF1 and type 3 Saukett strain. It is supplied in vial or pre-filled syringe, with no thimerosal used in the production.
zika virus vaccine
All Products
Viral Vaccines
Inactivated Vero-cell Rabies vaccine (Vero-Rabies)
Indications
Prevention of Rabies infection
GMP compliance
WHO-PQ
Dosage & instruction of use
1ml, Intramuscular injection; 0.1ml, intradermal injection
Shelf life
3 years
Description
Rabies vaccine is used to prevent infection caused by the Rabies virus and it can be used before or after exposure to the virus. Our Rabies vaccine is made using Pitman-Moore strain and prepared on vero-cells with chromatography purification. This product is supplied in freeze-dried vial form along with diluent for reconstitution.
vaccine technology transfer
All Products
Pharmaceuticals & Biosimilars
New Chemical Entity (NCE), Ethical (ETC) and Over the Counter (OTC) Drugs
Description
Drugs for various indications are available, ranging from Cardiovascular, Endocrinology, Diabetes, Circulatory, Gastrointestinal, Anti-infectives, Neurology, Respiratory, Urinary, Analgesics, Oncology, Dermatology to Digestive, Health Supplements, Cold relief and Others. In addition, biosimilars can also be supplied.
vaccine research and development
All Products
Others
Recombinant Rabies monoclonal antibody (Rabies mAb)
Indications
Prevention of Rabies infection
GMP compliance
WHO
Dosage & instruction of use
3.3IU/kg, Wound infiltration & intramuscular injection
Shelf life
3 years
Description
Rabies mAb is given to individuals with suspected Category III rabies exposure and it is to be applied in conjunction with Rabies vaccine for post-exposure prophylaxis. It provides fast neutralization of the Rabies virus infection which is a fatal disease. This is the first new generation substitution for anti-rabies immunoglobulin (HRIG and ERIG) in the world. Production by recombinant technology and chromatography purification ensure batch to batch consistency and high quality. This product is supplied in 100IU/2.5ml vial and it is free from animal or human origin material.